Abstract
Pancreatic carcinoma is a very aggressive disease with a very low 5-year relative survival rate of only 8%. The survival rate may be higher when the disease is localized, however, only about 9% of the cases are diagnosed in an early stage. There are no effective therapies or well established early detection methods. Therefore, early detection of the disease is the best chance of treatment…